NIHR Biomedical Research Centre
The BRC aims to quickly and effectively translate scientific findings about the genetic and molecular basis of cancer into therapeutic strategies which are tested in national trials.
The Royal Marsden, together with its academic partner, The Institute of Cancer Research (ICR), is designated as the UK's only National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) dedicated solely to cancer.
This award was made in 2006 by the NIHR and we were re-awarded this status in 2011.
It was decided to provide £62 million in funding over five years and shared among eight research themes. The research themes are:
- Cancer genetics
- Cancer imaging
- Cancer therapeutics
- Clinical studies
- Molecular pathology
Clinical research projects within the BRC relate to:
- Improved methods for diagnosing cancer
- Profiling cancers into different genetic and molecular subtypes
- Developing novel treatment strategies with targeted drugs
- Evaluating selective radiotherapy techniques
- Enhanced methods for monitoring response to treatment.
The translational research carried out at the BRC follows through to larger national trials, and therefore has a key role in influencing clinical practice.
You can find out more about the BRC on its website.